YUNGSHIN
DEAD

Serial Number

77395587

Owner

YUNG SHIN PHARM. IND. CO., LTD.

Attorney

James M. Slattery

Filing Date

Feb 13, 2008

Add to watchlist:

No watchlists yet
View on USPTO

YUNGSHIN Trademark

Serial Number: 77395587 • Registration: 3908356

YUNGSHIN is a trademark filed by YUNG SHIN PHARM. IND. CO., LTD. on February 13, 2008. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

YUNG SHIN PHARM. IND. CO., LTD. (18 trademarks)

NO. 1191, SEC. 1, CHUNG SHAN RD.
TAICHIA TAICHUNG , TW

Entity Type: 03

Trademark Details

Filing Date

February 13, 2008

Registration Date

January 18, 2011

Published for Opposition

March 24, 2009

Cancellation Date

August 20, 2021

Goods & Services

Gastro-intestinal treatment preparations; cough drops; calcium supplement; analgesic preparations; oral analgesics; anti-inflammatories; anesthetics for surgical and non-surgical uses; sedatives; respiratory stimulants; pharmaceutical preparations to enhance digestion; antacids; nausea treatment preparation; diarrhea medications; laxatives; diuretic preparations; antibiotics; hemostatics; appetite suppressants for medical use; diet pills; medicated hair restoration lotions; hair growth stimulants; medicated scalp treatment cream; smoking cessation preparations; eczema treatment preparations; hemorrhoid treatment preparations; psoriasis treatment preparations; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of arthritis; cough treatment preparations; highly caffeinated energy pills; breath-freshening chewing gum for medicinal purposes; blood plasma; antianginal preparation; acne treatment preparations; antipyretic analgesic; muscle relaxants; pharmaceutical anti-allergic preparations and substances; antidepressants; pharmaceutical preparations for the treatment of epilepsy, pharmaceutical preparations for the treatment of stomach ulcers, pharmaceutical preparations for the treatment of tuberculosis, pharmaceutical preparations for the treatment of Parkinson's disease, pharmaceutical preparations for the treatment of rheumatism, pharmaceutical preparations for the treatment of thrombosis, pharmaceutical preparations for the treatment of enuresis, pharmaceutical preparations for the treatment of hypertension, pharmaceutical preparations for the treatment of dermatosis; steroid ointments; human hormone for human use; pharmaceutical preparations for the prevention and treatment of disorders of the immune system; antihistamines; bronchodilators; pharmaceutical preparations for skin care; syringes sold filled with hyaluronic acid for use in arthroscopic surgeries; pharmaceutical preparations for the treatment of eye diseases and conditions; anti-cancer preparations; pharmaceutical preparations for treating diabetes; cholesterol reducers; hypnotics; preparations for treating colds; antiarrhythmics; oxytocics; expectorants; uterine contraction pharmaceutical preparations; contraceptives; athletes foot preparations; patches containing mosquito-repellent incenses for human use; vitamins; Chinese medicines, namely, herb teas for medicinal purposes, pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceuticals, namely, inducers of erections; hepatotonic agents for hepatological diseases; pharmaceutical preparations for the treatment of liver diseases; vaccines for human purposes; antivirals; ointments for pharmaceutical purposes, namely, non-steroid anti-inflammatory ointments; ocular pharmaceuticals, namely, eye-wash; patches containing anti-inflammatories; pharmaceutical preparations for hemopoiesis; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; pharmaceutical preparations for burn treatment; gelatin capsules sold empty for pharmaceuticals; suppositories; insect-repellents; pregnancy test kits for home use; diagnostic test kits consisting of diagnostic preparations for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; ovulation test kits; mineral nutritional supplements; dietary supplements in capsules containing garlic extract; medicinal ganoderma lucidum extracts for medical purposes; food supplements, namely, anti-oxidants; dietary supplements containing shark cartilage; vitamin and mineral supplements; dietary supplements in capsule forms containing shark liver oils; dietary supplements in capsule forms containing chitin extract; bread that is gluten-free to accommodate special medical and health conditions; dietary and nutritionally fortified food products adapted for medical use; dietary fiber powder as an additive for food products for restricted diet; dandruff shampoo

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Aug 20, 2021 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 18, 2020 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 6, 2016 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 6, 2016 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 6, 2016 APRE
TEAS SECTION 8 & 15 RECEIVED
Sep 26, 2016 E815
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2011 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 14, 2010 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Dec 13, 2010 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 11, 2010 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 6, 2010 SUPC
USE AMENDMENT FILED
Dec 2, 2010 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 2, 2010 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2010 EXRA
SOU EXTENSION 2 GRANTED
Jul 12, 2010 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 12, 2010 AITU
SOU EXTENSION 2 FILED
Jun 14, 2010 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 14, 2010 EEXT
SOU EXTENSION 1 GRANTED
Dec 7, 2009 EX1G
SOU EXTENSION 1 FILED
Dec 7, 2009 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 7, 2009 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 16, 2009 NOAM
PUBLISHED FOR OPPOSITION
Mar 24, 2009 PUBO
NOTICE OF PUBLICATION
Mar 4, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 14, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 2, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 2, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 2, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 2, 2009 CNEA
AMENDMENT FROM APPLICANT ENTERED
Dec 12, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2008 CRFA
ASSIGNED TO LIE
Dec 12, 2008 ALIE
PAPER RECEIVED
Dec 1, 2008 MAIL
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 30, 2008 GNRN
NON-FINAL ACTION E-MAILED
May 30, 2008 GNRT
NON-FINAL ACTION WRITTEN
May 30, 2008 CNRT
ASSIGNED TO EXAMINER
May 27, 2008 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Feb 20, 2008 MDSC
NEW APPLICATION ENTERED
Feb 19, 2008 NWAP